Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Peter Crooks

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Crooks, Peter

Item TypeName
Concept Leukemia, Lymphocytic, Chronic, B-Cell
Concept Leukemia
Concept Leukemia, Myeloid, Acute
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Concept Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Academic Article Antileukemic activity of aminoparthenolide analogs.
Academic Article An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Academic Article Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture.
Academic Article Melampomagnolide B: a new antileukemic sesquiterpene.
Academic Article The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.
Academic Article Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
Academic Article Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
Academic Article Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.
Academic Article Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
Academic Article Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.
Academic Article Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Academic Article Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Academic Article Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
Academic Article Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
Grant Novel melampomagnolide B-based prodrugs for the treatment of leukemia

Search Criteria
  • Leukemia